PHARMCHEM, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.6 USD | -7.14% |
|
+3.59% | 0.00% |
| 2022 | PharmChem, Inc.'s Equity Buyback announced on May 2, 2022, has cancelled. | CI |
| 2022 | PharmChem, Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2001 | 43.98M 3.67B | Sales 2002 | 30.08M 2.51B | Capitalization | 1.35M 112M |
|---|---|---|---|---|---|
| Net income 2001 | -8M -667M | Net income 2002 | 3M 250M | EV / Sales 2001 | 0.37 x |
| Net Debt 2001 | 10.89M 908M | Net Debt 2002 | 2.32M 194M | EV / Sales 2002 | 0.12 x |
| P/E ratio 2001 |
-0.66
x | P/E ratio 2002 |
0.4
x | Employees | - |
| Yield 2001 * |
-
| Yield 2002 |
-
| Free-Float | 96.52% |
More Fundamentals
* Assessed data
More press releases
| 1 day | -7.14% | ||
| 1 week | +3.59% | ||
| Current month | -5.45% | ||
| 1 month | -4.06% | ||
| 3 months | -13.33% |
1 week
2.51
2.80
1 month
2.512.95
Current year
2.513.57
1 year
2.103.57
3 years
1.205.80
5 years
0.695.80
10 years
0.025.80
| Managers | Title | Age | Since |
|---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Shana Veale
DFI | Director of Finance/CFO | - | 01/17/01 |
Douglas Crook
COO | Chief Operating Officer | - | 01/97/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Tim Eriksen
CHM | Chairman | 55 | 31/21/31 |
James Ford
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/24/15 | 2.6 | -7.14% | 1,400 |
| 14/24/14 | 2.8 | +7.69% | 12,000 |
| 13/24/13 | 2.6 | +1.96% | 3,984 |
| 10/24/10 | 2.55 | -1.92% | 3,000 |
| 09/24/09 | 2.6 | +3.59% | 6,150 |
Delayed Quote OTC Markets, May 16, 2024 at 01:15 am IST
More quotes
PharmChem Inc. is engaged in selling and distributing the PharmChek Sweat Patch Device (PharmChek). PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. PharmChek functions as a storage device where drugs are retained on the absorbent pad for detection in the laboratory. PharmChek detects Marijuana, Cocaine, Opiates, Amphetamine, Methamphetamine, PCP, Fentanyl, Oxycodone, Oxymorphone, Hydrocodone, and Hydromorphone. Its products include PharmChek Overlay, PharmChek Analysis Panels, and PharmChek for the Workplace. The PharmChek Overlay is made of the same polyurethane film as the PharmChek Sweat Patch and can be used to extend the wear time of the PharmChek Sweat patch. It is used in various industries, such as oil and gas field and marine environments, manufacturing, utilities, mining, transportation, and aerospace/aviation.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 13.01M | |
| -16.80% | 8.79B | |
| +67.50% | 4.19B | |
| -4.03% | 2.48B | |
| -42.54% | 2.29B | |
| -6.49% | 1.97B | |
| -20.45% | 1.56B | |
| -41.24% | 1.22B | |
| +10.26% | 1.13B | |
| +18.74% | 933M |
- Stock Market
- Equities
- PCHM Stock
